Novozymes A/S – (NVZMY) Given Hold Rating at Jefferies Group LLC

Jefferies Group LLC reaffirmed their hold rating on shares of Novozymes A/S – (NASDAQ:NVZMY) in a research report released on Thursday morning. Jefferies Group LLC currently has a $54.97 price objective on the biotechnology company’s stock.

Separately, Zacks Investment Research raised shares of Novozymes A/S – from a hold rating to a strong-buy rating and set a $52.00 price target for the company in a report on Thursday, August 10th. One research analyst has rated the stock with a sell rating, three have given a hold rating and two have issued a buy rating to the stock. The stock presently has a consensus rating of Hold and a consensus price target of $57.99.

Novozymes A/S – (NASDAQ NVZMY) traded up 0.42% during midday trading on Thursday, hitting $54.79. The stock had a trading volume of 17,415 shares. The stock’s 50-day moving average is $51.99 and its 200-day moving average is $46.85. Novozymes A/S – has a one year low of $31.57 and a one year high of $55.14. The company has a market cap of $16.17 billion and a P/E ratio of 33.23.

Novozymes A/S – (NASDAQ:NVZMY) last announced its quarterly earnings results on Friday, August 11th. The biotechnology company reported $0.36 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.39 by ($0.03). The firm had revenue of $522.72 million for the quarter. Equities analysts predict that Novozymes A/S – will post $1.68 EPS for the current fiscal year.

TRADEMARK VIOLATION WARNING: “Novozymes A/S – (NVZMY) Given Hold Rating at Jefferies Group LLC” was reported by Community Financial News and is the property of of Community Financial News. If you are reading this report on another publication, it was stolen and republished in violation of U.S. & international copyright and trademark legislation. The correct version of this report can be viewed at https://www.com-unik.info/2017/10/30/novozymes-as-nvzmy-given-hold-rating-at-jefferies-group-llc.html.

Novozymes A/S – Company Profile

Novozymes A/S is a Denmark-based biotechnology company engaged in the production and sale of industrial enzymes, microorganisms and biopharmaceutical ingredients. The Company operates in four geographical regions: Europe, Middle East & Africa (including Denmark), North America, Asia Pacific and Latin America.

Analyst Recommendations for Novozymes A/S - (NASDAQ:NVZMY)

What are top analysts saying about Novozymes A/S -? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Novozymes A/S - and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit